The covid-19 vaccine patent waiver: a crucial step towards a "people's vaccine".
Publication
, Journal Article
Gonsalves, G; Yamey, G
Published in: BMJ (Clinical research ed.)
May 2021
Duke Scholars
Altmetric Attention Stats
Dimensions Citation Stats
Published In
BMJ (Clinical research ed.)
DOI
EISSN
1756-1833
ISSN
0959-8138
Publication Date
May 2021
Volume
373
Start / End Page
n1249
Related Subject Headings
- General & Internal Medicine
- 52 Psychology
- 42 Health sciences
- 32 Biomedical and clinical sciences
- 1117 Public Health and Health Services
- 1103 Clinical Sciences
Citation
APA
Chicago
ICMJE
MLA
NLM
Gonsalves, G., & Yamey, G. (2021). The covid-19 vaccine patent waiver: a crucial step towards a "people's vaccine". BMJ (Clinical Research Ed.), 373, n1249. https://doi.org/10.1136/bmj.n1249
Gonsalves, Gregg, and Gavin Yamey. “The covid-19 vaccine patent waiver: a crucial step towards a "people's vaccine".” BMJ (Clinical Research Ed.) 373 (May 2021): n1249. https://doi.org/10.1136/bmj.n1249.
Gonsalves G, Yamey G. The covid-19 vaccine patent waiver: a crucial step towards a "people's vaccine". BMJ (Clinical research ed). 2021 May;373:n1249.
Gonsalves, Gregg, and Gavin Yamey. “The covid-19 vaccine patent waiver: a crucial step towards a "people's vaccine".” BMJ (Clinical Research Ed.), vol. 373, May 2021, p. n1249. Epmc, doi:10.1136/bmj.n1249.
Gonsalves G, Yamey G. The covid-19 vaccine patent waiver: a crucial step towards a "people's vaccine". BMJ (Clinical research ed). 2021 May;373:n1249.
Published In
BMJ (Clinical research ed.)
DOI
EISSN
1756-1833
ISSN
0959-8138
Publication Date
May 2021
Volume
373
Start / End Page
n1249
Related Subject Headings
- General & Internal Medicine
- 52 Psychology
- 42 Health sciences
- 32 Biomedical and clinical sciences
- 1117 Public Health and Health Services
- 1103 Clinical Sciences